Seems we will see some product launch, trials, or FDA news here sometime soon (update from 10Q period ending May 31):
CorLink&CorView:
99% complete
The cloud system is 98% complete, as the mechanism for sending and receiving studies is implemented with email notification along with the User management and security protocols. The mobile application is also 99-100% complete allowing for users to capture, analyze, process, manage and send 12 lead high resolution ECGs.
Cost to completion between $5,000 and $30,000 for FDA approvals and medical trials. This amount does not include marketing or sales costs which are not yet determined. For the purposes of our funding requirements we have used $30,000 for completion costs, but have not impacted any marketing or sales costs as those will be determined once the medical trials and FDA approvals have been received.
CorTab:
99% complete
From the date of acquisition of the project the Company has migrated from an embedded ECG solution to a Bluetooth based solution through the R&D process. A prototype, fully functional Unit is being tested at the moment on patients. The advanced tablet prototype was received from our manufacturer in China. The Bluetooth patient acquisition module was, manufactured and assembled in-house at the Cortronix headquarters. Arrangements have been made to begin production once orders are received.
During September 2013 the prototype for CorTab was received and tested and is mostly functional, ready for trials.
Testing costs fall within the Corview costs, defined above and the product will require FDA approvals and medical trials.
CorPak:
60%complete
The Company has selected the main device and platform to be used for the CorPak device. Testing on the main circuit has been successful, and is functioning properly. Tests continue to be implemented to bring about the definitive copy of the electrical schematic to remit to Noble Win International in China for implementation into the main device. Hardware designs have also been developed to provide an idea of how the device will ultimately look.
Cost to completion $48,000
CorCare:
40% complete.
This technology uses platform protocols in common with our other units, therefore the work on the other units can be directly implemented with CorCare thus furthering the development of this technology.
Cost to completion $50,000
CorCheck:
42% complete.
This technology is similar to CorCare in that they both use the same platform. Work on the previous platforms can therefore also be adopted for CorCheck. Research on the duel cells used for alcohol detection in breath is being done as well as finger print analysis.
Cost to completion $55,000
Total R&D funding: $183,000
